What’s new in the PerkinElmer reagent portfolio ?
New products using the HTRF® technology
Our team worked hard to provide you with no less than 14 new kits adding to the Cellular Phospho-Protein assays portfolio !
- BRD4, Total Kit
- BRD7, Total Kit
- BRD9, Total Kit
- CDK1, Total Kit
- CDK7, Total Kit
- CDK9, Total Kt
- CDK12, Total Kit
- CDK12, Total Kit
- Cyclin D1, Phospho-T286 Kit
- Cyclin D1, Total Kit
- IRF5, Total Kit
- MEK1, Phospho-S298 Kit
- p21, Total Kit
- SMAD4, Phospho-T277 Kit
- SMAD4, Total Kit
The Biomarkers assays portfolio have been enriched with two forms of an attractive target in Huntington disease treatment: the huntingtin protein (HTT).
In addition, we are proud to announce the launching of a new kit for CHO HCP detection :
New product using the AlphaLISA® technology
The CHO HCP kit is also available using the AlphaLISA® technology :
New products using the AlphaLISA® SureFire® Ultra™ technology
Finally, 16 new assays have been added to the Cellular Phospho-Protein assays portfolio !
New products flyer
Get our up-to-date listing of new products and find the related sales part numbers
